Financing ·
Radiopharm Theranostics Limited applied to the Australian Securities Exchange on August 3, 2026, for the quotation of…
RADXRadiopharm Theranostics Ltd
Radiopharm Theranostics Limited applied to the Australian Securities Exchange on August 3, 2026, for the quotation of 408,839,531 fully paid ordinary shares. These securities were issued as Tranche 1 of a placement announced on July 24, 2026, at an issue price of AUD 0.015 per share. The filing notes that further issues totaling 40 million ordinary shares and various warrants remain to complete the transaction. Radiopharm Theranostics Limited operates in the biotechnology industry, specializing in radiopharmaceuticals for theranostic applications.